Financials GE Vernova Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:02 24/06/2025 BST			5-day change	1st Jan Change
510.84 ^USD	+2.19%		+4.54%	+55.30%

06-24	Buy the Peace, Sell the War
06-24	Morgan Stanley Adjusts Price Target on GE Vernova to $511 From $422, Maintains Overweight Rating	MT

Fiscal Period: December	2023	2024	2025	2026	2027
Net sales ¹	-	34,935	36,949	40,310	44,199
Change	-	-	5.76%	9.1%	9.65%
EBITDA ¹	-	2,035	3,228	4,785	6,358
Change	-	-	58.61%	48.24%	32.88%
EBIT ¹	-	471	1,986	3,546	5,030
Change	-	-	321.61%	78.54%	41.87%
Interest Paid ¹	-	120	-75.5	-72.5	-64
Earnings before Tax (EBT) ¹	-130	2,498	2,753	4,279	5,829
Change	-	2,021.54%	10.21%	55.43%	36.23%
Net income ¹	-438	1,552	2,093	3,266	4,466
Change	-	454.34%	34.87%	56.05%	36.73%
Announcement Date	15/02/24	22/01/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1
Net sales ¹	7,260	8,204	8,913	10,559	8,032	8,782	9,237	10,928	8,693	9,463	10,100	11,932	9,642
Change	-	13%	8.64%	18.47%	-23.93%	9.34%	5.18%	18.3%	-20.45%	8.86%	6.73%	18.14%	-19.19%
EBITDA ¹	189	524	243	1,079	457	714.6	769.3	1,298	821.6	1,080	1,088	1,601	1,291
Change	-	177.25%	-53.63%	344.03%	-57.65%	56.36%	7.66%	68.71%	-36.69%	31.43%	0.8%	47.08%	-19.35%
EBIT ¹	-289	527	-359	593	43	404.8	461	956.3	561	844.9	832.5	1,301	1,027
Change	-	282.35%	-168.12%	265.18%	-92.75%	841.46%	13.87%	107.46%	-41.34%	50.61%	-1.47%	56.26%	-21.04%
Charge d'intérêts ¹	-14	60	36	38	56	-10	-10	-10	-	-	-	-	-1
Earnings before Tax (EBT) ¹	-96	1,602	-122	1,114	332	610.9	676.7	1,114	752.8	986.9	974.5	1,443	1,169
Change	-	1,768.75%	-107.62%	1,013.11%	-70.2%	84.01%	10.77%	64.57%	-32.4%	31.09%	-1.26%	48.06%	-18.97%
Net income ¹	-106	1,294	-96	484	254	467.3	514.6	874.2	548.9	717.1	713.7	1,112	899.3
Change	-	1,320.75%	-107.42%	604.17%	-47.52%	83.98%	10.12%	69.89%	-37.21%	30.64%	-0.47%	55.79%	-19.12%
Announcement Date	25/04/24	24/07/24	23/10/24	22/01/25	23/04/25	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2023	2024	2025	2026	2027
Net Debt ¹	-	-8,205	-9,058	-10,979	-13,787
Change	-	-	-10.4%	-21.21%	-25.58%
Announcement Date	15/02/24	22/01/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2024	2025	2026	2027
CAPEX ¹	883	950	1,001	1,032
Change	-	7.59%	5.35%	3.13%
Free Cash Flow (FCF) ¹	1,701	2,256	3,168	4,241
Change	-	32.65%	40.39%	33.87%
Announcement Date	22/01/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	-	5.83%	8.74%	11.87%	14.38%
EBIT Margin (%)	-	1.35%	5.37%	8.8%	11.38%
EBT Margin (%)	-	7.15%	7.45%	10.62%	13.19%
Net margin (%)	-	4.44%	5.66%	8.1%	10.1%
FCF margin (%)	-	4.87%	6.11%	7.86%	9.59%
FCF / Net Income (%)	-	109.6%	107.8%	96.98%	94.95%
Profitability
ROA	-	3.19%	3.72%	5.56%	7.23%
ROE	-	18.38%	20.4%	26.26%	29.69%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	2.53%	2.57%	2.48%	2.34%
CAPEX / EBITDA (%)	-	43.39%	29.43%	20.92%	16.23%
CAPEX / FCF (%)	-	51.91%	42.1%	31.6%	24.34%
Items per share
Cash flow per share ¹	-	9.291	12.48	13.57	15.18
Change	-	-	34.29%	8.78%	11.83%
Dividend per Share ¹	-	0.25	1.013	1.286	1.374
Change	-	-	305.36%	26.87%	6.86%
Book Value Per Share ¹	-	34.63	40.27	48.62	60.87
Change	-	-	16.27%	20.74%	25.2%
EPS ¹	-	5.58	7.461	11.68	16.03
Change	-	-	33.7%	56.52%	37.25%
Nbr of stocks (in thousands)	-	275,653	272,935	272,935	272,935
Announcement Date	-	22/01/25	-	-	-